Organigram Global Inc., Canada’s #1 cannabis company by market share, introduced happly, its third U.S. hemp-derived delta-9 brand, created particularly for the growing segment of consumers seeking ‘mindful recreation’ with THC products.
The launch of happly follows the Company’s entry into the growing U.S. hemp-derived THC market with its lineup of Collective Project sparkling juices and Fetch sodas earlier this year.
The hemp-derived THC category in the U.S. continues to experience growth driven by consumer access, convenience, discretion as well as wellness appeal.
The U.S. continues to demonstrate forward-thinking leadership in the acceptance and advancement of hemp-derived cannabinoids.
Organigram's new hemp-derived THC brand, happly, is designed for consumers seeking moderation, control, and predictability in their cannabis experiences. Backed by extensive qualitative and quantitative research, happly offers lower-dose formulations targeting specific mood states: Socialize, Relax, and Sleep. These products cater to the mindful recreation segment, which comprises approximately 21% of cannabinoid consumers. Notably, 63% of this demographic is below the age of 34, highlighting a major demand among younger adults for low-dose, functional cannabis cultivation products.
Executive Statement
According to Megan McCrae, SVP, Corporate Strategy & International Growth at Organigram, happly is more than just a new brand, it is about redefining how hemp-derived THC can be part of everyday life. It was designed by listening closely to consumers and creating a range of products they’ve been asking for with a focus on moderation, control, predictability and specific benefits. Most importantly, happly reflects an inclination toward intentional hemp-derived THC use—designed for everyday moments where consumers are seeking balance and being present rather than excess. their targeted formulas make that possible, offering the correct effects and a consistent experience.
